Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ATRC
NAMS
Add up to 3 more stocks
ATRC
AtriCure, Inc.
-4.77%
$53.68-2.69Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.73B
52W Range
$25.36 - $61.70
NAMS
NewAmsterdam Pharma Company N.V.
-2.32%
$22.27-0.53Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.60B
52W Range
$21.02 - $42.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 252.97 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.29 | 4.12 |
| P/S Ratio | 4.79 | 365.60 |
| P/FCF Ratio | 53.21 | N/A |
| EV/EBITDA | 75.80 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 76.2% | 92.2% |
| Operating Margin | 2.4% | -1002.9% |
| Net Margin | 1.9% | -3644.2% |
| ROE | 2.0% | -41.1% |
| ROA | 1.6% | -36.8% |
| ROIC | 2.0% | -38.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.22 | 9.03 |
| Quick Ratio | 3.19 | 9.03 |
| Debt/Equity | 0.14 | 0.00 |
| Interest Coverage | -0.59 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.